OR WAIT null SECS
Following the divestiture of its US Pharmaceutical Development Services business which included the rights to the AAIPharma name, AAIPharma Inc. has changed its name to ZeeCRO Inc.
ZeeCRO Inc. continues to provide early and late stage development services to its customers worldwide. These services include: Integrated early development services (EU), Pharmaceutical analysis (EU), Clinical trial supplies (EU, SA), Phase 1 (EU), Bioanalysis(NA, EU), Global clinical development services and Oncology development consulting.
The new global headquarters for ZeeCRO is located in Cary, North Carolina, USA.